Lung cancer ranks as the second most prevalent cancer, resulting in a high mortality rate. A significant challenge is that many individuals remain unaware of its presence until it has advanced and spread. Early detection is paramount in mitigating the severe consequences of lung cancer. While imaging scans serve as a primary screening method, they are typically reserved for those at elevated risk. Fortunately, scientists and researchers are actively exploring blood tests as potential diagnostic tools for detecting lung cancer.
While no definitive blood test for lung cancer has been established and implemented widely, preliminary results suggest that such tests could offer a less invasive means for early detection. Furthermore, these tests might provide insights into the specific type of lung cancer, guide treatment strategies, and inform long-term prognoses. A detailed discussion on this emerging diagnostic approach can be found in a recently published Healthline article.
